[Federal Register Volume 65, Number 166 (Friday, August 25, 2000)]
[Notices]
[Page 51813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21790]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Attenuated Dengue-2 
Virus Vaccine

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application Serial Number 09/
534,725 entitled ``Attenuated Dengue-2 Virus Vaccine'', filed March 24, 
2000. Foreign rights are also available. This patent application has 
been assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention provides vaccine compositions 
of attenuated dengue-2 virus. More specifically, the attenuated virus 
is produced by serial passage in PDK cells. The invention also provides 
methods for stimulating the immune system of an individual to induce 
protection against dengue-2 virus by administration of attenuated 
dengue-2 virus.

Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 00-21790 Filed 8-24-00; 8:45 am]
BILLING CODE 3710-08-P